| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e81c640698a3ce9aa192fd962d9595ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfd9b267e99132c91bdb706285523b6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3df1a3007948cf9cd0e899950d3ae91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa50e45a4804f280d44f14611192c422 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate |
2003-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d95fe8d5d2173cab1c1cb70ed305bedf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6296f22a867b14420a13f8aa8edcd8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6dc9f774c300a3c2285f5ea05b5284d |
| publicationDate |
2004-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004054497-A2 |
| titleOfInvention |
Use of a trpm8-activating substance for the treatment of tumours |
| abstract |
The invention relates to the use of a TRPM8-activating substance for producing a pharmaceutical composition for the treatment of tumour diseases in which TRPM8 is over-expressed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009526859-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7893072-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006040103-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005002582-A3 |
| priorityDate |
2002-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |